Respiratory Health Portfolio
A single-winner package pairing **diagnosis** and **treatment** for respiratory health. MucDx™ (diagnostics) complements MucRx™ (OTC relief), giving the acquirer a rare end-to-end platform: detect → treat → follow-up.
Quick Overview
What’s Included
- MucDx™ — diagnostics brand
- MucRx™ — OTC treatment brand
- Positioning copy & usage concepts
Why It Wins
- Owns the category story end-to-end
- Short, clinical brand names
- Built for retail + digital health
Status
Accepting verified buyer inquiries
Escrowed transfers supervised by the Association.
MucDx™ — Respiratory Diagnostics
Diagnose with Confidence
MucDx™ is a compact, clinical brand built on the universal medical shorthand “Dx” (diagnosis). It fits an at-home rapid test, smartphone-connected sensor, or clinic-grade device for respiratory illnesses and congestion.
- Use cases: COVID/flu/RSV panels, allergy markers, congestion scoring
- Digital features: AI cough/breath analysis, symptom journaling, telehealth exports
- Enterprise: EHR/EMR export, fleet/device management
MucRx™ — OTC Mucus Relief
The Prescription for Mucus — Over the Counter
MucRx™ is a shelf-ready OTC brand with immediate clarity: the prescription for mucus. It’s designed for syrups, 12-hour tablets, sprays, and lozenges — retail and DTC friendly, with modern branding.
- Benefits: thins & loosens mucus, relieves chest congestion (claims per formulation)
- Line extensions: adults/kids formulas, natural/herbal variants
- Channels: pharmacy, mass retail, marketplace, DTC
Why Package Them Together?
Single Narrative, Multiple SKUs
- Diagnose with MucDx™ → Treat with MucRx™
- Education + adherence programs drive retention
- Powerful retail & payer story: outcomes + convenience
Ideal Buyers
- Diagnostic & device manufacturers
- Pharma/OTC portfolios & private-label houses
- Digital health & telemedicine platforms
- Hospital/urgent care networks & retail pharmacy
Acquisition Summary
| Lot | Respiratory Health Portfolio — MucDx™ + MucRx™ |
|---|---|
| Type | Single-winner brand package (diagnostics + OTC) |
| Assets | Brand names, positioning, page content; (domains list if applicable) |
| Status | Accepting verified buyer inquiries |
| Transfer | Escrowed transfer supervised by the Association |
Final product claims and regulatory pathways (e.g., FDA, EU MDR) are determined by the acquirer.
© National Domain Association — Respiratory Health Portfolio